ALCAR logo

Carmat SA Stock Price

ENXTPA:ALCAR Community·€6.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

ALCAR Share Price Performance

€0.099
-0.71 (-87.72%)
€0.099
-0.71 (-87.72%)
Price €0.099

ALCAR Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk and slightly overvalued.

3 Risks
1 Reward

Carmat SA Key Details

€7.3m

Revenue

€43.7m

Cost of Revenue

-€36.3m

Gross Profit

€15.1m

Other Expenses

-€51.4m

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
-0.83
-494.88%
-699.82%
-168.5%
View Full Analysis

About ALCAR

Founded
2008
Employees
153
CEO
Stephane Piat
WebsiteView website
www.carmatsa.com

Carmat SA designs and develops total artificial heart for patients with advanced heart failure in France and internationally. The company offers Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.

Recent ALCAR News & Updates

Recent updates

No updates